A National Cancer Institute-designated Comprehensive Cancer Center

Make an appointment: 800-826-HOPE
Endocrine Fellowship Program Bookmark and Share

Endocrine Fellowship Program with Harbor-UCLA Medical Center

Background
The Endocrine Fellowship Program with Harbor-UCLA was expanded to include an additional site at City of Hope’s Department of Diabetes, Endocrinology & Metabolism, which offers advanced clinical programs in diabetes, thyroid cancer, neuroendocrine tumors, osteoporosis, calcium and electrolyte disturbances, and sexual and reproductive disorders. The department also offers several clinical and basic science research programs such as molecular signaling, hormonal factors and hormone discovery, cellular mechanisms of atherosclerosis, development of advanced glycation end-products (AGE) inhibitors and AGE breakers, as well as diabetic immunology and islet isolation, proliferation and transplantation. Additionally, joint studies with the departments of Hematology & Hematopoietic Cell Transplantation and Medical Oncology are being conducted to evaluate endocrine-related complications of cancer and cancer treatment.
 
Diabetes Training
Fellowship training at City of Hope focuses on treatment options for patients with diabetes, including patients with type 1, type 2 and those with drug and disease-induced forms of diabetes, such as that seen in cancer patients on steroid therapy and IV nutritional support. Fellows gain experience with advanced monitoring and treatment strategies for diabetes, including continuous glucose monitoring, oral medications and insulin pump therapy. At City of Hope, fellows also participate in the ongoing clinical islet transplantation program and are involved in the screening and follow-up care of islet transplant recipients with and without prior renal transplants. Training highlights also include experience with the diagnosis and management of diabetes-related complications and diabetes-associated disorders such as acute metabolic deteriorations, retinopathy, neuropathy, hyperlipidemia, hypertension, coronary disease, peripheral vascular disease and sexual dysfunction. Fellows also receive training on the implementation of non-drug strategies for the management of diabetes and its complications, including weight reduction and behavioral modification.
 
Other Endocrine Disorders
At City of Hope, fellows receive in-depth training in other endocrine disciplines, including: thyroid disorders and thyroid cancers, adrenal gland dysfunctions and tumors, pituitary gland disorders, metabolic abnormalities associated with cancer and its treatments, and osteoporosis and other metabolic bone diseases.
 
Program Benefits
The training at Harbor-UCLA is useful to City of Hope endocrine fellows as it provides an introduction in the care of underserved populations. Fellows gain experience with management of disease manifestations and disorders that are not frequently encountered in the populations seeking care at City of Hope (e.g., severe neuropathy requiring leg amputation and vision-threatening retinopathy) as well as gestational diabetes. Another benefit from City of Hope’s association with Harbor-UCLA is the continuing interactions with the faculty and trainees of each highly-rated program. Physicians participating in the joint fellowship program at City of Hope and Harbor-UCLA have the opportunity to receive training in islet transplantation that prepares them to meet the requirements set by the United Network of Organ Sharing, a national organ procurement agency, for establishing new islet transplantation centers.
 
Curriculum
City of Hope endocrinology fellows are primarily allocated to the City of Hope site, where they receive the majority of their training. A segment of their education is also completed at the Harbor-UCLA program site. Similarly, endocrine fellows at Harbor-UCLA have the opportunity to receive a portion of their training at City of Hope. This type of curriculum exposes fellows to a wide range of endocrine disciplines including: type 1 and type 2 diabetes, gestational diabetes, diabetes-related complications, diabetes-associated disorders, clinical islet transplantation, thyroid disorders and thyroid cancer, adrenal gland dysfunctions and tumors, pituitary gland disorders, metabolic abnormalities associated with cancer, osteoporosis and sexual dysfunction. Upon completion of the program, endocrine fellows are fully trained in the treatment and management of endocrinology-related diseases and disorders.
 
Training Requirements
Physicians with an M.D. degree at any stage of their postdoctoral training will be considered for the program. Preference is given to those who have completed residency in internal medicine, pediatrics, ob/gyn, urology or other related specialties. The program is also well suited for postdoctoral training for candidates with Ph.D. degrees. All candidates who have completed at least three years of residency in the United States must possess a California license to practice and do clinical training.
 
Program History
City of Hope was established in 1913 as a charitable hospital supported by a philanthropic volunteer organization. Today, the organization is dedicated to the prevention and cure of life-threatening diseases, such as cancer and diabetes, through both innovative research and compassionate patient care. City of Hope’s diabetes program was established in 1971 by Rachmiel Levine, M.D., and is currently led by Fouad R. Kandeel, M.D., Ph.D., in the Leslie & Susan Gonda (Goldschmied) Diabetes & Genetic Research Center, a state-of-the-art research building.
 

Endocrine Fellowship Program

Endocrine Fellowship Program with Harbor-UCLA Medical Center

Background
The Endocrine Fellowship Program with Harbor-UCLA was expanded to include an additional site at City of Hope’s Department of Diabetes, Endocrinology & Metabolism, which offers advanced clinical programs in diabetes, thyroid cancer, neuroendocrine tumors, osteoporosis, calcium and electrolyte disturbances, and sexual and reproductive disorders. The department also offers several clinical and basic science research programs such as molecular signaling, hormonal factors and hormone discovery, cellular mechanisms of atherosclerosis, development of advanced glycation end-products (AGE) inhibitors and AGE breakers, as well as diabetic immunology and islet isolation, proliferation and transplantation. Additionally, joint studies with the departments of Hematology & Hematopoietic Cell Transplantation and Medical Oncology are being conducted to evaluate endocrine-related complications of cancer and cancer treatment.
 
Diabetes Training
Fellowship training at City of Hope focuses on treatment options for patients with diabetes, including patients with type 1, type 2 and those with drug and disease-induced forms of diabetes, such as that seen in cancer patients on steroid therapy and IV nutritional support. Fellows gain experience with advanced monitoring and treatment strategies for diabetes, including continuous glucose monitoring, oral medications and insulin pump therapy. At City of Hope, fellows also participate in the ongoing clinical islet transplantation program and are involved in the screening and follow-up care of islet transplant recipients with and without prior renal transplants. Training highlights also include experience with the diagnosis and management of diabetes-related complications and diabetes-associated disorders such as acute metabolic deteriorations, retinopathy, neuropathy, hyperlipidemia, hypertension, coronary disease, peripheral vascular disease and sexual dysfunction. Fellows also receive training on the implementation of non-drug strategies for the management of diabetes and its complications, including weight reduction and behavioral modification.
 
Other Endocrine Disorders
At City of Hope, fellows receive in-depth training in other endocrine disciplines, including: thyroid disorders and thyroid cancers, adrenal gland dysfunctions and tumors, pituitary gland disorders, metabolic abnormalities associated with cancer and its treatments, and osteoporosis and other metabolic bone diseases.
 
Program Benefits
The training at Harbor-UCLA is useful to City of Hope endocrine fellows as it provides an introduction in the care of underserved populations. Fellows gain experience with management of disease manifestations and disorders that are not frequently encountered in the populations seeking care at City of Hope (e.g., severe neuropathy requiring leg amputation and vision-threatening retinopathy) as well as gestational diabetes. Another benefit from City of Hope’s association with Harbor-UCLA is the continuing interactions with the faculty and trainees of each highly-rated program. Physicians participating in the joint fellowship program at City of Hope and Harbor-UCLA have the opportunity to receive training in islet transplantation that prepares them to meet the requirements set by the United Network of Organ Sharing, a national organ procurement agency, for establishing new islet transplantation centers.
 
Curriculum
City of Hope endocrinology fellows are primarily allocated to the City of Hope site, where they receive the majority of their training. A segment of their education is also completed at the Harbor-UCLA program site. Similarly, endocrine fellows at Harbor-UCLA have the opportunity to receive a portion of their training at City of Hope. This type of curriculum exposes fellows to a wide range of endocrine disciplines including: type 1 and type 2 diabetes, gestational diabetes, diabetes-related complications, diabetes-associated disorders, clinical islet transplantation, thyroid disorders and thyroid cancer, adrenal gland dysfunctions and tumors, pituitary gland disorders, metabolic abnormalities associated with cancer, osteoporosis and sexual dysfunction. Upon completion of the program, endocrine fellows are fully trained in the treatment and management of endocrinology-related diseases and disorders.
 
Training Requirements
Physicians with an M.D. degree at any stage of their postdoctoral training will be considered for the program. Preference is given to those who have completed residency in internal medicine, pediatrics, ob/gyn, urology or other related specialties. The program is also well suited for postdoctoral training for candidates with Ph.D. degrees. All candidates who have completed at least three years of residency in the United States must possess a California license to practice and do clinical training.
 
Program History
City of Hope was established in 1913 as a charitable hospital supported by a philanthropic volunteer organization. Today, the organization is dedicated to the prevention and cure of life-threatening diseases, such as cancer and diabetes, through both innovative research and compassionate patient care. City of Hope’s diabetes program was established in 1971 by Rachmiel Levine, M.D., and is currently led by Fouad R. Kandeel, M.D., Ph.D., in the Leslie & Susan Gonda (Goldschmied) Diabetes & Genetic Research Center, a state-of-the-art research building.
 
APPLICATION
All endocrinology Internal Medicine applicants are through ERAS. Please go to the ERAS web site at for the application process.
CONTACT
Ken C. Chiu, M.D., F.A.C.E.
Program Site Director
Endocrinology Fellowship
Department of Clinical Diabetes, Endocrinology & Metabolism
City of Hope
1500 East Duarte Road
Duarte, CA 91010-3000
Phone: (626) 256-4673
E-mail Address: kchiu@coh.org
 
A request for additional information may be made to the Fellowship Coordinator through e-mail at kramos@coh.org.
Ranked as one of  "America’s Best Hospitals" in cancer by U.S. News & World Report, City of Hope is a pioneer in the fields of hematopoietic cell transplantation and genetics. Designated as a comprehensive cancer center, the highest honor bestowed by the National Cancer Institute, City of Hope's research and treatment protocols advance care throughout the nation.
 
City of Hope has a long-standing commitment to Continuing Medical Education (CME), sharing advances in cancer research and treatment with the health-care community through CME courses such as conferences, symposia and other on and off campus CME opportunities for medical professionals.
City of Hope’s Clinical Investigation Training Program (CITP) provides scholars with clinical research fundamentals and the comprehensive skill set required for today's comprehensive clinical investigator.
Residency and Fellowship Programs
Residency and Fellowship Programs City of Hope offers exciting and challenging clinical fellowship opportunities to expand your knowledge and professional expertise. Current Training Activities


NEWS & UPDATES
  • Surgery is vital in the treatment of cancer – it’s used to help diagnose, treat and even prevent the disease – so a new colorectal cancer study linking a decrease in surgeries for advanced cancer to increased survival rates may raise more questions than it answers for some patients. The surgery-and-surviv...
  • Age is the single greatest risk factor overall for cancer; our chances of developing the disease rise steeply after age 50. For geriatric oncology nurse Peggy Burhenn, the meaning is clear: Cancer is primarily a geriatric condition. That’s why she is forging inroads in the care of older adults with cancer. Burh...
  • One of American’s great sportscasters, Stuart Scott, passed away from recurrent cancer of the appendix at the young age of 49. His cancer was diagnosed when he was only 40 years old. It was found during an operation for appendicitis. His courageous fight against this disease began in 2007, resumed again with an...
  • When Homa Sadat found a lump in her breast at age 27, her gynecologist told her what many doctors say to young women: You’re too young to have breast cancer. With the lump dismissed as a harmless cyst, she didn’t think about it again until she was at a restaurant six months later and felt […]
  • What most people call a “bone marrow transplant” is not actually a transplant of bone marrow; it is instead the transplantation of what’s known as hematopoietic stem cells. Such cells are often taken from bone marrow, but not always. Hematopoietic stem cells are simply immature cells that can ...
  • Doctors have long known that women with a precancerous condition called atypical hyperplasia have an elevated risk of breast cancer. Now a new study has found that the risk is more serious than previously thought. Hyperplasia itself is an overgrowth of cells; atypical hyperplasia is an overgrowth in a distorted...
  • Don’t kid yourself. Just because it’s mid-January doesn’t mean it’s too late to make resolutions for a happier, and healthier, 2015. Just consider them resolutions that are more mature than those giddy, sometimes self-deluded, Jan. 1 resolutions. To that end, we share some advice from Cary A. Presant, M.D., an ...
  • Sales and marketing executive Jim Murphy first came to City of Hope in 2002 to donate blood for a friend who was being treated for esophageal cancer. The disease is serious. Although esophageal cancer accounts for only about 1 percent of cancer diagnoses in the U.S., only about 20 percent of patients survive at...
  • Aaron Bomar and his family were celebrating his daughter’s 33rd birthday in September 2014 when he received alarming news: According to an X-ray taken earlier that day at an urgent care facility, he had a node on his aorta and was in danger of an aneurysm. Bomar held hands with his wife and daughter and s...
  • Explaining a prostate cancer diagnosis to a young child can be difficult — especially when the cancer is incurable. But conveying the need for prostate cancer research, as it turns out, is easily done. And that leads to action. Earlier this year, Gerald Rustad, 71, who is living with a very aggressive form of m...
  • Cancer and its treatment can create unexpected daily challenges for patients. Side effects from chemotherapy, surgery and radiation therapy as well as the disease itself can cause difficulty in everything from speech to movement to eating. When this happens, rehabilitation is vital; it helps patients restore th...
  • Betsy Sauer and her four daughters share plenty in common. They’re smart and successful.  They’re funny, ranging from wryly witty to wickedly hilarious. Their hobbies tend toward the active and adventurous: hiking, rock climbing, skiing, swimming, fishing, kayaking, yoga and horseback riding. Also, they take he...
  • Flu season is upon us, and few people should take the risk of infection more seriously than cancer patients and their loved ones and caregivers. With the federal Centers for Disease Control and Prevention warning of widespread influenza outbreaks, it’s clear that flu season – and the associated risks – won’t en...
  • HIV/AIDS researchers are determined not only to cure the disease, but to develop ever-more-effective treatments until that ultimate goal is reached. In 2015, they will gain ground in both endeavors. In search of a cure: Stem cell and gene therapy One of the most promising prospects for curing HIV is to recreate...
  • Every year, researchers make gains in the understanding of cancer, and physicians make gains in the treatment of cancer. As a result, every year, more cancer patients survive their disease. In those ways, 2015 will be no different. What will be different are the specific research discoveries and the specific ad...